Legacy Capital Group California, Inc. Novartis Ag Transaction History
Legacy Capital Group California, Inc.
- $393 Billion
- Q3 2025
A detailed history of Legacy Capital Group California, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 3,189 shares of NVS stock, worth $419,512. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,189
Previous 2,959
7.77%
Holding current value
$419,512
Previous $358 Million
14.21%
% of portfolio
0.1%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,603Shares Held
137MCall Options Held
1.55MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...